FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / hsr-filing-analysis-memo.docx
hsr-filing-analysis-memo.docx · 1013-00006

Parties

Genome Dx Therapeutics Inc
Seller Genome Dx Therapeutics Inc
Gregg LLP
Brindoval Partners LLC
Harkness LLP
Westmark Corp
Granite Harbor Corp
Towne Centre Properties LLC

Dates

May 15, 2023
May 11, 2023
May 18, 2023
August 1, 2023
June 22, 2023
August 8, 2023
December 31, 2022
August 8, 2025
August 8, 2026
February 27, 2023

Amounts

$140,000,000
$126,000,000
$14,000,000
$111.4
$312,000,000
$4.2
$589,000,000
$104,000,000
$47,600,000
$8,000,000

Obligations

Applicability Tests — Two-Part Threshold Analysis The HSR Act establishes two independent tests that must be satisfied for the premerger notification requirement to apply: (1) the size-of-transaction test and (2) the size-of-person test
4 million for 2023) but does not exceed the higher threshold, the size-of-person test must also be satisfied: one party must have total assets or annual net sales of at least $222
7 million, and the other party must have total assets or annual net sales of at least $22
Consequently, the transaction is not reportable solely on the basis of the size-of-transaction test; the size-of-person test must also be satisfied
5 million, the analysis must proceed to the size-of-person test, which is addressed in Section V below
5 million, the size-of-person test must also be met for the filing obligation to be triggered